Results 151 to 160 of about 253,687 (260)
What's new? Mitogen‐activated protein kinase (MAPK) inhibitors are promising treatments for pediatric Langerhans cell histiocytosis (LCH), a rare heterogeneous neoplasm that often affects multiple organ systems. Which MAPK inhibitors are most effective against LCH remains uncertain.
Xue Tang +5 more
wiley +1 more source
Adrenocorticotropic hormone combined with vigabatrin as a second-line therapy for West syndrome. [PDF]
Souza LP +5 more
europepmc +1 more source
Epilepsy and Neurodevelopmental Outcomes in a Cohort of West Syndrome Beyond Two Years of Age. [PDF]
Aramanadka R +5 more
europepmc +1 more source
Long‐Term Course of West Syndrome Associated with Tuberous Sclerosis [PDF]
Katsuyuki Fukushima +3 more
openalex +1 more source
Abstract Objective This study aimed to investigate maternal and neonatal outcomes of pregnancies complicated by pre‐eclampsia (PE) in Indonesia and analyze regional variations in risk factors and clinical outcomes across the country. Methods A multicenter retrospective cohort study was conducted in 30 hospitals located across five major islands in ...
Muhammad Ilham Aldika Akbar +49 more
wiley +1 more source
Epidemiological predictors of metabolic syndrome in urban West Bengal, India
SasthiNarayan Chakraborty +2 more
openalex +1 more source
Abstract Introduction To evaluate the accuracy and completeness of responses across common obstetrical and gynecologic topics generated by the large language models (LLMs) ChatGPT and Google Gemini, which have become increasingly popular for patients seeking medical information before physician consultations.
Madeline West +6 more
wiley +1 more source
Corticotherapy versus adrenocorticotropic hormone for treating West syndrome: a systematic review and meta-analysis. [PDF]
Farias EH +8 more
europepmc +1 more source
What Matters the Most for Hormonal Therapy in West Syndrome: Drug, Dosage, or Duration? [PDF]
Sahu JK, Madaan P.
europepmc +1 more source

